Invention Grant
US07939662B2 Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same
失效
无定形齐拉西酮盐酸盐（5- [2- [4-（1,2-苯并异噻唑-3-基）-1-哌嗪基]乙基] -6-氯-1,3-二氢-2H-吲哚-2-酮盐酸盐） 并进行生产
![Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same](/docs/US/2011-05-10/US07939662B2/abs.jpg.600x600.jpg)
- Patent Title: Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same
- Patent Title (中): 无定形齐拉西酮盐酸盐（5- [2- [4-（1,2-苯并异噻唑-3-基）-1-哌嗪基]乙基] -6-氯-1,3-二氢-2H-吲哚-2-酮盐酸盐） 并进行生产
-
Application No.: US11987926Application Date: 2007-12-06
-
Publication No.: US07939662B2Publication Date: 2011-05-10
- Inventor: Carlos Zetina-Rocha , Allan W. Rey , Matthew A. Buck , Lotfi Derdour , Stephen E. Horne , Keshava K. S. Murthy
- Applicant: Carlos Zetina-Rocha , Allan W. Rey , Matthew A. Buck , Lotfi Derdour , Stephen E. Horne , Keshava K. S. Murthy
- Applicant Address: CA Branford
- Assignee: Apotex Pharmachem Inc.
- Current Assignee: Apotex Pharmachem Inc.
- Current Assignee Address: CA Branford
- Priority: CA2467538 20040514
- Main IPC: C07D417/00
- IPC: C07D417/00
![Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same](/abs-image/US/2011/05/10/US07939662B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to a new and useful amorphous form of ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and preparations thereof.
Public/Granted literature
Information query
